Page 321 - AIDSBK23C
P. 321
Page 321
288 Tincati C, Biasin M, Bandera A, Violin M, Marchetti G, Piacentini L, Vago GL, et al.
Early initiation of highly active antiretroviral therapy fails to reverse immunovirological
abnormalities in gut-associated lymphoid tissue induced by acute HIV infection. Antivir
Ther. 2009;14:321-330.
289 Luzuriaga K, Bryson Y, Krogstad P, et al. Combination treatment with zidovudine,
didanosine, and nevirapine in infants with human immunodeficiency virus type I
infection. N Engl J Med. 1997;336:1343-1349.
290 Gortmaker SL, Hughes M, Servia J, et al. Effect of combination therapy including
protease inhibitors on mortality among children and adolescents infected with HIV-1. N
Engl J Med. 2001;345:1522-1528.
291 McIntyre J. Strategies to prevent mother-to-child transmission of HIV. Curr Opin Infect
Dis. 2006;19:33-38.
292 Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal
Transmission. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-
Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV
Transmission in the United States. May 24, 2010; pp 1-117. Available at
http://aidsinfo.nih.gov/ContentFiles/PerinatalGL.pdf. Accessed (April 7, 2011).
293 Wade NA, Birkhead GS, Warren BL, et al. Abbreviated regimens of zidovudine
prophylaxis and perinatal transmission of the human immunodeficiency virus. N Engl J
Med. 1998;339:1409-1414.
294 Hart CE, Lennox JL, Pratt-Palmore M, et al. Correlation of human immunodeficiency
virus type 1 RNA levels in blood and the femal genital tract. J Infect Dis. 1999;179:871-
882.
295 Monge S, Jarrín I, Pérez-Hoyos S, et al; GEMES. Educational level and HIV disease
progression before and after the introduction of HAART: a cohort study in 989 HIV
seroconverters in Spain. Sex Transm Infect. 2011;87(7):571-576.
296 Descamps D, Flandre P, Calvez V, et al. Mechanisms of virologic failure in previously
untreated HIV-infected patients from a trial of induction-maintenance therapy. JAMA.
2000;283:205-211.
297 SMART Study Group. CD4+ count-guided interruption of antiretroviral treatment. N
Engl J Med. 2006;355:2283-2296.
298 Ledergerber B, Egger M, Opravil M, et al. Clinical progression and virological failure on
highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Lancet.
1999;353: 863-868.
